Harmonization of magnetic resonance-based manual hippocampal segmentation: A mandatory step for wide clinical use

[1]  Nick C. Fox,et al.  A meta-analysis of hippocampal atrophy rates in Alzheimer's disease , 2009, Neurobiology of Aging.

[2]  S. Gauthier,et al.  Effect of tramiprosate in patients with mild-to-moderate alzheimer’s disease: Exploratory analyses of the MRI sub-group of the alphase study , 2009, The journal of nutrition, health & aging.

[3]  Alexander Hammers,et al.  Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: Method and validation , 2009, NeuroImage.

[4]  Martin Styner,et al.  A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes , 2009, NeuroImage.

[5]  J. Brewer,et al.  Fully-Automated Quantification of Regional Brain Volumes for Improved Detection of Focal Atrophy in Alzheimer Disease , 2009, American Journal of Neuroradiology.

[6]  Michael Weiner,et al.  and the Alzheimer’s Disease Neuroimaging Initiative* , 2007 .

[7]  C. Jack,et al.  Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI , 2008, Neurobiology of Aging.

[8]  B. Vellas,et al.  Endpoints for trials in Alzheimer's disease: a European task force consensus , 2008, The Lancet Neurology.

[9]  J. Barnes,et al.  A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus , 2008, NeuroImage.

[10]  Sterling C. Johnson,et al.  Hippocampal volume change in the Alzheimer Disease Cholesterol-Lowering Treatment trial. , 2008, Cleveland Clinic journal of medicine.

[11]  Miia Kivipelto,et al.  The Atorvastatin/Donepezil in Alzheimer’s Disease Study (LEADe): Design and baseline characteristics ⁎ ⁎ Roy W. Jones and Miia Kivipelto contributed equally to the content of the manuscript. , 2008, Alzheimer's & Dementia.

[12]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[13]  Nick C Fox,et al.  Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease , 2005, Neurology.

[14]  J. Bremner,et al.  MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed , 2005, Molecular Psychiatry.

[15]  C. Jack,et al.  Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.

[16]  S. Duchesne,et al.  Appearance-Based Segmentation of Medial Temporal Lobe Structures , 2002, NeuroImage.

[17]  C. Jack,et al.  Functional inferences vary with the method of analysis in fMRI , 2000, NeuroImage.

[18]  M. Bobinski,et al.  The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease , 1999, Neuroscience.

[19]  H. Soininen,et al.  MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. , 1998, AJNR. American journal of neuroradiology.

[20]  Nick C. Fox,et al.  The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI , 1997, IEEE Transactions on Medical Imaging.

[21]  Edith V. Sullivan,et al.  Volumetric MRI assessment of temporal lobe structures in schizophrenia , 1994, Biological Psychiatry.

[22]  F Andermann,et al.  Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging , 1992, Neurology.

[23]  C. Jack,et al.  Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. , 1989, Radiology.

[24]  N. Qizilbash.  Evidence based dementia practice , 2002 .